BioXcel Therapeutics, Inc. Operating Lease, Expense
BioXcel Therapeutics, Inc. (BTAI) reported Operating Lease, Expense of $101.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2026-08-13
- BioXcel Therapeutics, Inc. operating lease, expense for the quarter ending 2026-06-30 was $101.00K, a 0.00% change year-over-year.
- BioXcel Therapeutics, Inc. operating lease, expense for the quarter ending 2026-03-31 was $103.00K, a 1.98% increase year-over-year.
- BioXcel Therapeutics, Inc. operating lease, expense for the quarter ending 2025-12-31 was $103.00K, a 8.42% increase year-over-year.
- BioXcel Therapeutics, Inc. operating lease, expense for the quarter ending 2025-09-30 was $104.00K, a 2.97% increase year-over-year.
- BioXcel Therapeutics, Inc. operating lease, expense for fiscal 2025 was $410.00K, a 4.06% increase from fiscal 2024.
- BioXcel Therapeutics, Inc. operating lease, expense for fiscal 2024 was $394.00K, a 0.51% increase from fiscal 2023.
- BioXcel Therapeutics, Inc. operating lease, expense for fiscal 2023 was $392.00K, a 4.39% decline from fiscal 2022.
- BioXcel Therapeutics, Inc. operating lease, expense for fiscal 2022 was $410.00K, a 12.33% increase from fiscal 2021.
| Period end | Operating Lease, Expense 3 month | Operating Lease, Expense 3 month as first filed | Operating Lease, Expense 6 month | Operating Lease, Expense 6 month as first filed | Operating Lease, Expense 9 month | Operating Lease, Expense 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $101.00K 10-Q · filed 2026-08-13 | $204.00K 10-Q · filed 2026-08-13 | $307.00K derived: sum of 3 quarters · filed 2026-08-13 | $411.00K derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2026-03-31 | $103.00K 10-Q · filed 2026-05-15 | $206.00K derived: sum of 2 quarters · filed 2026-05-15 | $310.00K derived: sum of 3 quarters · filed 2026-05-15 | $411.00K derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2025-12-31 | $103.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $207.00K derived: sum of 2 quarters · filed 2026-03-27 | $308.00K derived: sum of 3 quarters · filed 2026-08-13 | $410.00K 10-K · filed 2026-03-27 | ||
| 2025-09-30 | $104.00K 10-Q · filed 2025-11-12 | $205.00K derived: sum of 2 quarters · filed 2026-08-13 | $307.00K 10-Q · filed 2025-11-12 | $401.00K derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2025-06-30 | $101.00K 10-Q · filed 2026-08-13 | $202.00K 10-Q · filed 2026-08-13 | $297.00K derived: sum of 3 quarters · filed 2026-08-13 | $398.00K derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2025-03-31 | $101.00K 10-Q · filed 2026-05-15 | $196.00K derived: sum of 2 quarters · filed 2026-05-15 | $297.00K derived: sum of 3 quarters · filed 2026-05-15 | $396.00K derived: sum of 4 quarters · filed 2026-05-15 | ||
| 2024-12-31 | $95.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $196.00K derived: sum of 2 quarters · filed 2026-03-27 | $295.00K derived: sum of 3 quarters · filed 2026-03-27 | $394.00K 10-K · filed 2026-03-27 | ||
| 2024-09-30 | $101.00K 10-Q · filed 2025-11-12 | $200.00K derived: sum of 2 quarters · filed 2025-11-12 | $299.00K 10-Q · filed 2025-11-12 | $397.00K derived: sum of 4 quarters · filed 2025-11-12 | ||
| 2024-06-30 | $99.00K 10-Q · filed 2025-08-12 | $198.00K 10-Q · filed 2025-08-12 | $296.00K derived: sum of 3 quarters · filed 2025-08-12 | $394.00K derived: sum of 4 quarters · filed 2025-08-12 | ||
| 2024-03-31 | $99.00K 10-Q · filed 2025-05-12 | $197.00K derived: sum of 2 quarters · filed 2025-05-12 | $295.00K derived: sum of 3 quarters · filed 2025-05-12 | $394.00K derived: sum of 4 quarters · filed 2025-05-12 | ||
| 2023-12-31 | $98.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $196.00K derived: sum of 2 quarters · filed 2025-03-28 | $295.00K derived: sum of 3 quarters · filed 2025-03-28 | $392.00K 10-K · filed 2025-03-28 | ||
| 2023-09-30 | $98.00K 10-Q · filed 2024-11-14 | $197.00K derived: sum of 2 quarters · filed 2024-11-14 | $294.00K 10-Q · filed 2024-11-14 | $388.00K derived: sum of 4 quarters · filed 2024-11-14 | ||
| 2023-06-30 | $99.00K 10-Q · filed 2024-08-06 | $98.00K 10-Q · filed 2023-08-14 | $198.00K 10-Q · filed 2024-08-06 | $197.00K 10-Q · filed 2023-08-14 | $290.00K derived: sum of 3 quarters · filed 2024-08-06 | $404.00K derived: sum of 4 quarters · filed 2024-08-06 |
| 2023-03-31 | $99.00K 10-Q · filed 2024-05-09 | $191.00K derived: sum of 2 quarters · filed 2024-05-09 | $305.00K derived: sum of 3 quarters · filed 2024-05-09 | $412.00K derived: sum of 4 quarters · filed 2024-05-09 | ||
| 2022-12-31 | $92.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | $206.00K derived: sum of 2 quarters · filed 2024-03-22 | $313.00K derived: sum of 3 quarters · filed 2024-03-22 | $410.00K 10-K · filed 2024-03-22 | ||
| 2022-09-30 | $114.00K 10-Q · filed 2023-11-14 | $221.00K derived: sum of 2 quarters · filed 2023-11-14 | $318.00K 10-Q · filed 2023-11-14 | $404.00K derived: sum of 4 quarters · filed 2023-11-14 | ||
| 2022-06-30 | $107.00K 10-Q · filed 2023-08-14 | $204.00K 10-Q · filed 2023-08-14 | $290.00K derived: sum of 3 quarters · filed 2023-08-14 | $375.00K derived: sum of 4 quarters · filed 2023-08-14 | ||
| 2022-03-31 | $98.00K 10-Q · filed 2023-05-09 | $183.00K derived: sum of 2 quarters · filed 2023-05-09 | $268.00K derived: sum of 3 quarters · filed 2023-05-09 | $353.00K derived: sum of 4 quarters · filed 2023-05-09 | ||
| 2021-12-31 | $85.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $170.00K derived: sum of 2 quarters · filed 2023-03-16 | $255.00K derived: sum of 3 quarters · filed 2023-03-16 | $365.00K 10-K · filed 2023-03-16 | ||
| 2021-09-30 | $85.00K 10-Q · filed 2022-11-14 | $170.00K derived: sum of 2 quarters · filed 2022-11-14 | $280.00K 10-Q · filed 2022-11-14 | $387.00K derived: sum of 4 quarters · filed 2022-11-14 | ||
| 2021-06-30 | $85.00K 10-Q · filed 2022-08-11 | $194.00K 10-Q · filed 2022-08-11 | $302.00K derived: sum of 3 quarters · filed 2022-08-11 | $432.00K derived: sum of 4 quarters · filed 2022-08-11 | ||
| 2021-03-31 | $109.00K 10-Q · filed 2022-05-09 | $217.00K derived: sum of 2 quarters · filed 2022-05-09 | $347.00K derived: sum of 3 quarters · filed 2022-05-09 | $401.00K derived: sum of 4 quarters · filed 2022-05-09 | ||
| 2020-12-31 | $108.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $238.00K derived: sum of 2 quarters · filed 2022-03-11 | $292.00K derived: sum of 3 quarters · filed 2022-03-11 | $345.00K 10-K · filed 2022-03-11 | ||
| 2020-09-30 | $130.00K 10-Q · filed 2021-11-10 | $184.00K derived: sum of 2 quarters · filed 2021-11-10 | $237.00K 10-Q · filed 2021-11-10 | $238.00K derived: sum of 4 quarters · filed 2021-11-10 | ||
| 2020-06-30 | $54.00K 10-Q · filed 2021-08-10 | $108.00K 10-Q · filed 2021-08-10 | $108.00K derived: sum of 3 quarters · filed 2021-08-10 | |||
| 2020-03-31 | $54.00K 10-Q · filed 2021-05-10 | $54.00K derived: sum of 2 quarters · filed 2021-05-10 | ||||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $155.00K 10-K · filed 2021-03-12 | ||||
| 2019-09-30 | $155.00K 10-Q · filed 2020-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |